Nutrients & HIV Newsletter 
Vol 3. 07
March 2007  
Dear Doctor,

Welcome to this month's edition of Nutrients & HIV newsletter. To unsubscribe please click the email address at the bottom of the page and send a blank email to us.

Due to the large number of requests on previous issues of this newletter, we have posted all the previous issues on our website and can be accessed at www.lighthousepharma.com/immunace.htm

  In this issue: Vitamin Supplementation of HIV infected women improves postnatal child growth.
 
1: Am J Clin Nutr. 2005 Apr;81(4):880-8. 

Vitamin supplementation of HIV-infected women improves postnatal child growth.

Department of Nutrition and Community Health, Muhimbili University College of Health Sciences, Dar es Salaam, Tanzania. evillamo@hsph.harvard.edu

BACKGROUND: Linear growth retardation and wasting are common in children born to HIV-infected women. Inexpensive interventions that could improve the postnatal growth pattern of such children are needed. 

OBJECTIVE: The objective was to examine the effect of supplementing HIV-infected women with multivitamins or vitamin A and beta-carotene, during and after pregnancy, on the growth of their children during the first 2 y of life. 

DESIGN: We conducted a randomized placebo-controlled trial in 886 mother-infant pairs in Tanzania. At the first prenatal visit, HIV-infected women were randomly assigned to 1 of 4 daily oral regimens in a 2 x 2 factorial fashion: multivitamins (MV: thiamine, riboflavin, vitamin B-6, niacin, vitamin B-12, vitamin C, vitamin E, and folic acid), preformed vitamin A + beta-carotene (VA/BC), MV including VA/BC, or placebo. Supplementation continued during the first 2 y postpartum and thereafter. Children were weighed and measured monthly, and all received vitamin A supplements after 6 mo of age per the standard of care. 

RESULTS: Multivitamins had a significant positive effect on attained weight (459 g; 95% CI: 35, 882; P = 0.03) and on weight-for-age (0.42; 95% CI: 0.07, 0.77; P = 0.02) and weight-for-length (0.38; 95% CI: 0.07, 0.68; P = 0.01) z scores at 24 mo. VA/BC seemed to reduce the benefits of MV on these outcomes. No significant effects were observed on length, midupper arm circumference, or head circumference. 

CONCLUSION: Supplementation of HIV-infected women with multivitamins (vitamin B complex, vitamin C, and vitamin E) during pregnancy and lactation is an effective intervention for improving ponderal growth in children.

PMID: 15817867 [PubMed - indexed for MEDLINE]

For a full Clinical paper - Click Here
NEW!  ----- IMMUNACE tablets
IMMUNACE is a comprehensive spectrum of 22 antioxidant, vitamins and essential nutrients specifically designed to help maintain immune resistance and long-term cell protection. 

It is the ONLY product in this category with a clinical trial that has been published in a reputable medical journal - AIDS (The Official Journal of International AIDS Society). www.aidsonline.com. IMMUNACE has been studied in an independent double blind cross-over study. World-renowned institution the London School of Hygiene and Tropical Medicine, University of London, conducted the published trial. Trial participants were followed up every 12 weeks for a total of 48 weeks during which a statistically significant benefit was found in the group taking IMMUNACE. Click here for more details.

IMMUNACE IS NOT A REPLACEMENT FOR ARV TREATMENT OR BALANCED DIET. IT COMPLEMENTS HIV/AIDS MANAGEMENT DUE TO THE HIGH NUTRITIONAL REQUIREMENTS OF THESE PATIENTS

IMMUNACE is currently approved for reimbursement to HIV/AIDS patients in the following medical aid schemes:

  • Aid for Aids patients (MedScheme now Solutio) i.e. Bonitas, GEMS, Liberty, Medshield, etc
  • Status Medical Aid Administrators i.e. Protea Medical Aid, Grintek, Lifemed, Compcare, Goodhope etc

Old!

Immunace 30 Capsules


New! 

 Immunace 30 Tablets

 
Lighthouse Pharma
Tel: +27-11-392 4307
Cell: +27-72-048 1199
Fax: +27-11-825 7663
Visit: www.lighthousepharma.com
Email: admin@lighthousepharma.com
Member Services
1. We respect your privacy. If you would prefer not to receive this newsletter or emails,  just reply a blank email to this address: unsubscribe@lighthousepharma.com
2. If you have any questions and would like to contact us then please e-mail us at immunace@lighthousepharma.com or visit http://www.immunace.com for detailed product information